Newly Awarded Grants

The Leukemia & Lymphoma Society (SCOR grant)

Title: Targeting Unmet Needs For B-cell Lymphomas
Principal Investigator: Ethel Cesarman, MD PhD (Project 2 Lead)
Period of Support: 10/01/2022-09/30/2027 
Total Direct Costs: $750,000 (Project 2)

National Institutes of Health (U01 grant subaward)

Title: Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
Principal Investigator: Ethel Cesarman, MD PhD
Period of Support: 06/10/2022-05/31/2027 
Total Direct Costs: $361,050

National Institutes of Health (U01 grant)

Title: B cell determinants of EBV latency
Principal Investigator: Ethel Cesarman, MD PhD
Period of Support: 09/09/2022-08/31/2027 
Total Direct Costs: $3,158,148

National Institutes of Health (T32 grant)

Title: Cancer Research Manpower
Principal Investigator: Ethel Cesarman, MD PhD; Co-PI: Matthew Greenblatt, MD PhD
Period of Support: 09/01/2022-08/31/2027 
Total Direct Costs: $1,474,686

National Institutes of Health (K99 grant)

Title: A multi-stem cell basis for craniosynostosis
Principal Investigator: Shawon Debnath, PhD
Period of Support:  07/01/2022-06/30/2024
Total Direct Costs: $250,000

United States Department of Defense

Title: The skeletal stem cell basis for skeletal fragility
Principal Investigator: Shawon Debnath, PhD
Period of Support:  12/15/2022-12/14/2024
Total Direct Costs: $200,000

American Society for Bone and Mineral Research

Title: A multi-stem cell basis for craniosynostosis
Principal Investigator: Shawon Debnath, PhD
Period of Support:  01/01/2023-12/31/2023
Total Direct Costs: $15,000

National Institutes of Health (R01 grant)

Title: Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis
Principal Investigator: Nancy Du, PhD
Period of Support: 08/01/2022-07/31/2027 
Total Direct Costs: $1,143,750

Charles A. Frueauff Foundation

Title: Equipment purchase for osteoporosis research
Principal Investigator: Matthew Greenblatt, MD PhD
Period of Support: 01/01/2023-12/31/2023
Total Direct Costs: $40,000

Pershing Square Foundation

Title: A bone to brain axis controlling Alzheimer’s disease progression
Principal Investigator: Matthew Greenblatt, MD PhD
Period of Support: 07/01/2023-06/30/2026
Total Direct Costs: $675,000

National Institutes of Health (R44 subaward)

Title: Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 08/18/2022-07/31/2023
Total Direct Costs: $123,894

National Institutes of Health (R01 supplement grant)

Title: Epigenetic alterations and phenotypes in innate immune cells and their progenitors in PASC
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 08/08/2022-11/30/2024
Total Direct Costs: $177,089

STARR Cancer Consortium

Title: Mechanisms oof dynamic chromatin reorganization regulating B-cell differentiation and lymphomagenesis
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 01/01/2023-12/31/2024
Total Direct Costs: $200,000

Burroughs Wellcome Fund

Title: Epigenetic regulation of immunity: molecular mechanisms of inflammatory priming and altered hematopoiesis
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 07/01/2022-06/30/2027
Total Direct Costs: $500,000 

National Institutes of Health (R35 grant)

Title: Destruction of noncoding RNAs 
Principal Investigator: Benjamin Kleaveland, MD PhD
Period of Support: 07/01/2022-06/30/2027 
Total Direct Costs: $1,250,000 

Prostate Cancer Foundation

Title: Targeting lipid metabolism and diet in patients with locally advanced prostate cancer
Principal Investigator: Massimo Loda, MD
Period of Support: 12/23/2022-12/22/2024
Total Direct Costs: $1,000,000

National Institutes of Health (U54 subaward)

Title: Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center
Principal Investigator: Luigi Marchionni, MD PhD
Period of Support: 08/04/2022-07/31/2027
Total Direct Costs: $640,020

National Institutes of Health (R01 grant)

Title: Cholesterol metabolism in mesenchymal colorectal cancer
Principal Investigator: Jorge Moscat, PhD
Period of Support: 12/09/2022-11/30/2027
Total Direct Costs: $1,543,195 

National Institutes of Health (R50 grant)

Title: Dissecting the in vivo stromal metabolic and inflammatory crosstalk in colorectal cancer
Principal Investigator: Maria Angeles Duran Molina, PhD/Jorge Moscat, PhD (Unit Director)
Period of Support: 8/16/2022-7/31/2027
Total Direct Costs: $524,435

Qatar National Research Foundation

Title: Differences in methylation profiles of prostate cancer (PCa) patients with different genetic ancestry 
Principal Investigator: Juan Miguel Mosquera, MD
Period of Support: 11/01/2022-12/31/2022
Total Direct Costs: $300,000 

National Institutes of Health (DP5 Diversity Supplement)

Title: Defining malignant hematopoiesis via single-cell multi-omics 
Principal Investigator: Anna Nam, MD
Period of Support: 09/01/2022-08/30/2024 
Total Direct Costs: $126,126 

Scipio Bioscience

Title: Identifying signatures of metastatic disease using genetically engineered mouse models (GEMMS) of locally advanced and metastatic prostate cancer
Principal Investigator: Mohamed Omar PhD (Marchionni Lab)
Period of Support: 04/01/2023-03/31/24
Total Direct Costs: $30,000

National Institutes of Health (R01 supplement grant)

Title: Endothelial sphingolipid siignaling in post-sepsis cognitive impairment
Principal Investigator: Teresa Sanchez Garcia-Vao, PhD
Period of Support: 06/15/2022-05/31/2025
Total Direct Costs: $250,000

National Institutes of Health (R13 grant)

Title: 2nd Biennial ASBMB - BSC Symposium on the Interplay between Epigenetic Regulation and Genome Integrity
Principal Investigator: Jessica Tyler, PhD
Period of Support: 08/15/2022-07/31/2023
Total Direct Costs: $9,600

National Institutes of Health (R43 SBIR subaward)

Title: High-resolution genomic mapping of ssDNA and associated priteins for Alzheimer’s disease research
Principal Investigator: Jessica Tyler, PhD
Period of Support: 09/01/2022-06/30/2023
Total Direct Costs: $88,496

National Institutes of Health (R01 subaward) 

Title:  Development of Targeted Antipseudomonal Bactericidal Prodrugs 
Principal Investigator: Lars Westblade, PhD
Period of Support: 04/01/2023-03/31/2028 
Total Direct Costs: $200,000 

National Institutes of Health (R01 grant)

Title: UBR5's mechanisms of action in tumorigenesis and immunoregulation
Principal Investigator: Pengbo Zhou, PhD (Co-PI Xiaojing Ma)
Period of Support: 03/01/2023-02/28/2028
Total Direct Costs: $611,590 

 

Weill Cornell Medicine Internal Grants

Cornell China Center

Title: A stem cell basis for vertebral metastases
Principal Investigator: Matthew Greenblatt, MD PhD
Period of Support: 07/01/2023-06/30/2024
Total Direct Costs: $15,000

Weill Cornell Medicine Dean’s Office (Jumpstart award)

Title: A Tri-stem cell basis for calvarial mineralization and neuroinflammatiion
Principal Investigator: Seoyeon Bok, PhD
Period of Support: 07/01/2022-06/30/2025
Total Direct Costs: $300,000 

Meyer Cancer Center Collaborative Research Initiative

Title: Characterization of Alternative polyadenylation as a determinant of tumor progression and immunotherapy response
Principal Investigator: Luigi Marchionni, MD PhD
Period of Support: 07/01/2022-06/30/2023
Total Direct Costs: $50,000

Cornell Center for Pandemic Prevention and Response 

Title:  Clinical utility of viral load quantification in influenza infections 
Principal Investigator: Lars Westblade, PhD
Period of Support: 12/01/2022-11/30/2023 
Total Direct Costs: $75,000  

WCM Clinical & Translational Science Center

Title: Effects of In-Utero SARS-Cov-2 exposure and immunity on pediatric outcomes
Principal Investigator: Yawei (Jenny) Yang, MD PhD
Period of Support: 07/01/2022-06/30/2023
Total Direct Costs: $50,000

WCM Clinical & Translational Science Center

Title: WCM Clinical and Translational Science Center (CTSC)
Principal Investigator: Pengbo Zhou, PhD
Period of Support: 07/01/2022-06/30/2023
Total Direct Costs: $50,000

National Institutes of Health/WCM (SPORE DRP Pilot grant)

Title: Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
Principal Investigator: Massimo Loda, MD; PI Pilot Award: Pengbo Zhou, PhD
Period of Support: 10/01/2022-09/30/2023
Total Direct Costs: $75,000

 

Industry Sponsored Research Agreements 

Selux Diagnostics

Title: Performance comparison of rapid Antimicrobial Susceptibility Test (AST) system for clinical isolate colonies
Principal Investigator: Lars Westblade, PhD
Period of Support: 08/01/2022-07/31/2023
Total Direct Costs: $28,203

Vividion Therapeutics

Title: Sponsored Research Agreement
Principal Investigator: Giorgio Inghirami, MD
Period of Support: 01/01/2023-12/31/2023
Total Direct Costs: $32,253

Chimerix, Inc.

Title: Development of Next-Generation Therapeutics for Advanced Prostate Cancer
Principal Investigator: David Rickman, PhD
Period of Support: 09/30/2022-09/29/2023
Total Direct Costs: $100,125

 

Fellowships

National Institutes of Health (UM1 Fellowship) 

Title: The AIDS Malignancy Consortium Grant (AMC)
Principal Investigator: Sanjay Patel, MD
Period of Support: 09/01/2022- 08/31/2023
Total Direct Costs: $25,000

National Institutes of Health (UM1 Fellowship) 

Title: The AIDS Malignancy Consortium Grant (AMC)
Principal Investigator: Paul Simonson, MD, PhD
Period of Support: 09/01/2022- 08/31/2023
Total Direct Costs: $25,000

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700